Cefuroxime and Tiazac drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cefuroxime and Tiazac. Common interactions include anxiety among females and death among males.

The phase IV clinical study analyzes what interactions people who take Cefuroxime and Tiazac have. It is created by eHealthMe based on reports of 6 people who take Cefuroxime and Tiazac from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Mar, 24, 2023

6 people who take Cefuroxime and Tiazac together, and have interactions are studied.


What is Cefuroxime?

Cefuroxime has active ingredients of cefuroxime sodium. It is often used in sinusitis. eHealthMe is studying from 12,650 Cefuroxime users for its effectiveness, alternative drugs and more.

What is Tiazac?

Tiazac has active ingredients of diltiazem hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 4,500 Tiazac users for its effectiveness, alternative drugs and more.

Number of Cefuroxime and Tiazac reports submitted per year:

Cefuroxime and Tiazac drug interactions.

Common Cefuroxime and Tiazac drug interactions by gender *:

female:

  1. Anxiety
  2. Injury
  3. Pain
  4. Anaemia
  5. Angina pectoris
  6. Aphasia
  7. Arthralgia
  8. Atrial fibrillation
  9. Back pain
  10. Blood chloride decreased

male:

  1. Death
  2. Drug ineffective
  3. Fear
  4. Hypoaesthesia
  5. Injury
  6. Neutropenia
  7. Organ failure
  8. Pain
  9. Phlebitis
  10. Platelet count decreased

Common Cefuroxime and Tiazac drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anhedonia
  2. Anxiety
  3. Depression
  4. Emotional distress
  5. Fear
  6. Injury
  7. Multi-organ failure
  8. Nervousness
  9. Pain
  10. Renal failure

50-59:

  1. Drug ineffective
  2. Pulmonary embolism
  3. Anaemia
  4. Angina pectoris
  5. Anxiety
  6. Aphasia
  7. Arthralgia
  8. Atrial fibrillation
  9. Back pain
  10. Blood chloride decreased

60+:

  1. Anhedonia
  2. Anxiety
  3. Injury
  4. Organ failure
  5. Pain
  6. Renal failure
  7. Renal impairment
  8. Renal injury
  9. Wheezing
  10. Cardiac disorder

* Approximation only. Some reports may have incomplete information.

Do you take Cefuroxime and Tiazac?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Cefuroxime and Tiazac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Cefuroxime side effects:

Browse all side effects of Cefuroxime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Tiazac side effects:

Browse all side effects of Tiazac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Cefuroxime interactions:

Browse all interactions between Cefuroxime and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Tiazac interactions:

Browse all interactions between Tiazac and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cefuroxime sodium and diltiazem hydrochloride (the active ingredients of Cefuroxime and Tiazac, respectively), and Cefuroxime and Tiazac (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Cefuroxime and Tiazac.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: